Ultragenyx Pharmaceutical News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

11.11.24	Ultragenyx Presents Positive Update On GTX-102 Angelman Syndrome Program (RTTNews)
05.11.24	Ultragenyx Pharmaceutical Inc Q3 Loss Decreases, Beats Estimates (RTTNews)
07.10.24	Ultragenyx Pharmaceutical Reports FDA Designation Of Setrusumab As Breakthrough Therapy (RTTNews)
02.08.24	Ultragenyx Pharma Q2 Loss Narrows; Lifts FY Revenue Guidance; Stock Up In After-hours (RTTNews)
14.06.24	Ultragenyx Pharma Prices Public Offering Of About 7.44 Mln Shares At $39.00/shr (RTTNews)
12.06.24	Ultragenyx: Phase 2/3 Study Of Setrusumab Shows Fracture Reductions In Osteogenesis Imperfecta (RTTNews)
15.04.24	Ultragenyx Reports Positive Interim Phase 1/2 Data With GTX-102 - Quick Facts (RTTNews)
15.02.24	Ultragenyx Pharmaceutical Inc Q4 Loss decreases, beats estimates (RTTNews)
08.01.24	Ultragenyx Pharma Sees FY23 Total Revenue Below View (RTTNews)
04.01.24	Ultragenyx Pharma Gets Positive Recommendation From NICE For Evkeeza (RTTNews)
18.12.23	Ultragenyx Receives European Commission Decision for Evkeeza® (evinacumab) Expanded Indication in Children Aged 5 Years and Older with Homozygous Familial Hypercholesterolemia (HoFH) (GlobeNewswire)
01.09.23	Zur Behandlung der homozygoten familiären Hypercholesterinämie (HoFH): Ultragenyx führt Evkeeza® (Evinacumab) in Deutschland ein (GlobeNewswire)
03.08.23	Ultragenyx Pharmaceutical Inc Q2 Loss misses estimates (RTTNews)
06.06.23	Pre-market Movers: FRZA, GTLB, GGE, CDRE, ZURA… (RTTNews)
04.05.23	Ultragenyx Pharmaceutical Inc Q1 Loss increases, misses estimates (RTTNews)
03.11.22	Ultragenyx Pharma Q3 Loss Widens (RTTNews)
26.09.22	Pre-market Movers: BHIL, GSUN, NUV, HRTG, EFSH… (RTTNews)
05.05.22	Ultragenyx Pharmaceutical Inc Q1 Loss increases, misses estimates (RTTNews)
11.02.22	Ultragenyx Q4 Loss Widens (RTTNews)
29.11.21	Ultragenyx Reports Additional Positive Durability Data For DTX401, DTX301 Gene Therapies (RTTNews)
02.11.21	Ultragenyx Pharmaceutical Inc Q3 Profit beats estimates (RTTNews)
09.09.21	MEDIA ADVISORY: Ultragenyx Announces Mepsevii® (vestronidase alfa) Receives Reimbursement Approval for Treatment of Mucopolysaccharidosis VII in Italy (GlobeNewswire)
13.07.21	MEDIA ADVISORY: Ultragenyx Announces Mepsevii® (vestronidase alfa) Receives Reimbursement Approval for Treatment of Mucopolysaccharidosis VII in Spain (GlobeNewswire)
11.02.21	Ultragenyx Pharmaceutical Q4 Loss Widens (RTTNews)
08.01.21	Ultragenyx Reports Positive Longer-term Data From Phase 1/2 Studies Of DTX401, DTX301 (RTTNews)
18.12.20	Stock Alert: Mereo BioPharma Soars 50% On Collaboration Deal With Ultragenyx (RTTNews)
28.10.20	Ultragenyx Pharma Q3 Loss Narrows (RTTNews)
26.06.20	Biotech Stocks Facing FDA Decision In July 2020 (RTTNews)
19.06.20	FDA OKs First Therapy To Treat Tumor-induced Osteomalacia (RTTNews)
19.06.20	FDA Nod For EPZM, RARE, Court Rules In MYL's Favor, Ocuphire To Hop Onto Nasdaq, ALPN Soars (RTTNews)
26.05.20	Biotech Stocks Facing FDA Decision In June 2020 (RTTNews)
10.01.20	AGTC Catches Eyes, PTLA Bleeds As Antidote Sales Disappoint, RARE Jumps (RTTNews)
23.01.19	Aphria In Focus, UBX To Report Phase I Data In Q2, RARE On Track (RTTNews)
15.11.18	MNK Awaits D-Day, AMEH In Good Health, AXSM To Report ASCEND Data In Jan. (RTTNews)
06.11.18	AKAO Hits New Low, INSY Shifts Focus From Opioids, FDA Nod For Theratechnologies (RTTNews)
05.11.18	Ultragenyx Pharmaceutical Q3 Loss Widens (RTTNews)
29.10.18	ESPR To Submit NDAs In Q1, GRFS' Alzheimer's Study Brings Hope, RTRX On Watch (RTTNews)
26.10.18	Ultragenyx Discontinues Development Of UX007 In Glut1 DS Indication (RTTNews)
18.10.18	Ultragenyx : Brazil Okays Mepsevii For Treatment Of Mucopolysaccharidosis VII (RTTNews)
27.09.18	Ultragenyx Reports Positive Topline Cohort 2 Results From DTX301 Study (RTTNews)
29.08.18	FDA Accepts Ultragenyx's Proposal To Submit NDA For UX007 For Treatment LC-FAOD (RTTNews)
28.08.18	AFMD Soars On Genentech Deal, AKCA Slumps On Rejection, FDA Nod For TTPH (RTTNews)
14.07.18	Week Ahead In Pharmaceuticals - 7 Stocks To Watch (RTTNews)
29.06.18	Ultragenyx Announces Positive CHMP Opinion For Mepsevii (RTTNews)
08.05.18	It's Raining FDA Approvals, MSON Muscling Up, RDHL To Report Data In Aug. (RTTNews)
18.04.18	GWPH Faces FDA Panel Today, NVCR Reports STELLAR Data, 1st XLH Drug Cleared (RTTNews)
14.04.18	An Ear To The Pharma: 9 Stocks To Watch This Week (RIGL, RARE, TROV, DVAX...) (RTTNews)
28.03.18	Biotech Stocks Facing FDA Decision In April (RTTNews)
26.02.18	KMPH Gets FDA Nod, ADMP On Track, OBSV To Report Data Today (RTTNews)
21.02.18	AIMT Meets Study Goals, TTPH Keeps Hopes Alive, Opportunities Galore For TXMD (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Ultragenyx Pharmaceutical Inc

Aktien Top/Flop

Meistgelesene Nachrichten